Skip Navigation

Vaccine Safety Bibliography-April 2014

1. Adegboye OA, Kotze D, Adegboye OA. Multi-year trend analysis of childhood immunization uptake and coverage in Nigeria. J Biosoc Sci. 2014 Mar; 46(2):225-39.

2. Alexander AB, Stupiansky NW, Ott MA, Herbenick D, Reece M, Zimet GD. What Parents and Their Adolescent Sons Suggest for Male HPV Vaccine Messaging. Health  Psychol. 2014 Mar 3. [Epub ahead of print].

3. Amodio E, Restivo V, Firenze A, Mammina C, Tramuto F, Vitale F. Can influenza  vaccination coverage among healthcare workers influence the risk of nosocomial influenza-like illness in hospitalized patients? J Hosp Infect. 2014 Mar; 86(3):182-7.

4. Andrews SM, Pollard AJ. A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty. Lancet Infect Dis. 2014 Mar 24.

5. Apenteng BA, Opoku ST. Employee influenza vaccination in residential care facilities. Am J Infect Control. 2014 Mar;42(3):294-9.

6. Arencibia Jiménez M, Navarro Gracia JF, Delgado de Los Reyes JA, Pérez Torregrosa G, López Parra D, López García P. Missed Opportunities in Antipneumococcal Vaccination. Can Something More be Done for Prevention? Arch Bronconeumol. 2014 Mar;50(3):93-98.

7. Awasthi S, Belshe RB, Friedman HM. Better neutralization of HSV-1 than HSV-2 by antibody from subjects immunized with the GlaxoSmithKline gD2 vaccine. J Infect Dis. 2014 Mar 20. [Epub ahead of print].

8. Azzari C, Martinón-Torres F, Schmitt HJ, Dagan R. Evolving Role of 13-Valent Pneumococcal Conjugate Vaccine in Clinical Practice. Pediatr Infect Dis J. 2014 Mar 10. [Epub ahead of print]

9. Ball R. Perspectives on the future of postmarket vaccine safety surveillance  and evaluation. Expert Rev Vaccines. 2014 Mar 7. [Epub ahead of print].

10. Barker CI, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis. 2014 Mar;14(3):227-238.

11. Barlow RS, Reynolds LE, Cieslak PR, Sullivan AD. Vaccinated Children and Adolescents with Pertussis Infections Have Decreased Illness Severity and Duration, Oregon 2010-2012. Clin Infect Dis. 2014 Mar 14. [Epub ahead of print].

12. Bash MC, Lynn F, Mocca B, Borrow R, Findlow H, Hassan-King M, Preziosi MP, Idoko O, Sow S, Kulkarni P, Laforce M. Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers. Clin Vaccine Immunol. 2014 Mar 26. [Epub ahead of print].

13. Batista-Duharte A, Portuondo D, Pérez O, Carlos IZ. Systemic immunotoxicity reactions induced by adjuvanted vaccines. Int Immunopharmacol. 2014 Mar 6;20(1):170-180. [Epub ahead of print].

14. Baxter R, Reisinger K, Block SL, Izu A, Odrljin T, Dull P. Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents. J Pediatr. 2014 Mar 20. [Epub ahead of print].

15. Beau AB, Hurault-Delarue C, Vidal S, Guitard C, Vayssière C, Petiot D, Montastruc JL, Damase Michel C, Lacroix I. Pandemic A/H1N1 influenza vaccination  during pregnancy: a comparative study using the EFEMERIS database. Vaccine. 2014 Mar 5;32(11):1254-8.

16. Beel ER, Rench MA, Montesinos DP, Healy CM. Acceptability of immunization in  adult contacts of infants: Possibility of expanding platforms to increase adult vaccine uptake. Vaccine. 2014 Mar 26. [Epub ahead of print].

17. Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, Dupont HL. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis. 2014 Mar;14(3):197-204.

18. Belshe RB, Heineman TC, Bernstein DI, Bellamy AR, Ewell M, van der Most R, Deal CD. Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women. J Infect Dis. 2014 Mar; 209(6):828-36.

19. Berenson AB, Male E, Lee TG, Barrett A, Sarpong KO, Rupp RE, Rahman M. Assessing the need for and acceptability of a free-of-charge postpartum HPV vaccination program. Am J Obstet Gynecol. 2014 Mar; 210(3):213.e1-7.

20. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, Juvekar S, Muliyil J, Arya A, Shaikh H, Abraham  V, Vrati S, Proschan M, Kohberger R, Thiry G, Glass R, Greenberg HB, Curlin G, Mohan K, Harshavardhan GV, Prasad S, Rao TS, Boslego J, Bhan MK; for the India Rotavirus Vaccine Group. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014 Mar 11. [Epub ahead of print].

21. Biscayart C, Carrega ME, Sagradini S, Gentile A, Stecher D, Orduna T, Bentancourt S, Jiménez SG, Flynn LP, Arce GP, Uboldi MA, Bugna L, Morales MA, Digilio C, Fabbri C, Enría D, Diosque M, Vizzotti C. Yellow fever vaccine-associated adverse events following extensive immunization in Argentina.  Vaccine. 2014 Mar 5;32(11):1266-72.

22. Bonaparte M, Dweik B, Feroldi E, Meric C, Bouckenooghe A, Hildreth S, Hu B, Yoksan S, Boaz M. Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India. BMC Infect Dis. 2014 Mar 21; 14:156.

23. Bottino CJ, Cox JE, Kahlon PS, Samuels RC. Improving Immunization Rates in a  Hospital-Based Primary Care Practice. Pediatrics. 2014 Mar 24. [Epub ahead of print].

24. Bradley-Stewart A, Miller R, Maclean A, Aitken C, Whittaker L, Gregory V, Daniels R, Gunson R. Cluster of influenza A cases in vaccinated population of adults in Virology Laboratory in Glasgow in December 2012. Scott Med J. 2014 Mar 21. [Epub ahead of print].

25. Brenzel L. Can investments in health systems strategies lead to changes in immunization coverage? Expert Rev Vaccines. 2014 Apr;13(4):561-72.

26. Brotman RM, Ravel J, Bavoil PM, Gravitt PE, Ghanem KG. Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine  development against sexually transmitted infections. Vaccine. 2014 Mar 20;32(14):1543-52.

27. Browning MJ, Lim MT, Kenia P, Whittle M, Doffinger R, Barcenas-Morales G, Kumararatne D, Viskaduraki M, O'Callaghan C, Gaillard EA. Pneumococcal polysaccharide vaccine responses are impaired in a subgroup of children with cystic fibrosis. J Cyst Fibros. 2014 Mar 10. [Epub ahead of print].

28. Bugvi AS, Rahat R, Zakar R, Zakar MZ, Fischer F, Nasrullah M, Manawar R. Factors associated with non-utilization of child immunization in Pakistan: evidence from the Demographic and Health Survey 2006-07. BMC Public Health. 2014  Mar 6;14(1):232.

29. Butler T. Plague history: Yersin's discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines. Clin Microbiol Infect. 2014 Mar; 20(3):202-9.

30. Buyantseva LV, Horwitz A. Food allergies are rarely a concern when considering vaccines for adolescents. J Am Osteopath Assoc. 2014 Mar; 114(3 Suppl  1):S18-21.

31. Börjesson M, Enander A. Perceptions and sociodemographic factors influencing  vaccination uptake and precautionary behaviours in response to the A/H1N1 influenza in Sweden. Scand J Public Health. 2014 Mar;42(2):215-22.

32. Campins Martí M, Uriona Tuma S. [General epidemiology of infections acquired  by health-care workers: Immunization of health-care workers.]. Enferm Infecc Microbiol Clin. 2014 Mar 19. [Epub ahead of print].

33. Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O. Differences in Antibody Responses Between Trivalent Inactivated Influenza Vaccine and Live Attenuated Influenza Vaccine Correlate With the Kinetics and Magnitude of Interferon Signaling in Children. J Infect Dis. 2014 Mar 24. [Epub ahead of print].

34. Cassidy B, Braxter B, Charron-Prochownik D, Schlenk EA. A Quality Improvement Initiative to Increase HPV Vaccine Rates Using an Educational and Reminder Strategy With Parents of Preteen Girls. J Pediatr Health Care. 2014 Mar-Apr; 28(2):155-64.

35. Chan TC, Fan-Ngai Hung I, Ka-Hay Luk J, Chu LW, Hon-Wai Chan F. Effectiveness of influenza vaccination in institutionalized older adults: a systematic review.  J Am Med Dir Assoc. 2014 Mar;15(3):226.e1-6.

36. Chang WC, Yen C, Wu FT, Huang YC, Lin JS, Huang FC, Yu HT, Chi CL, Lin HY, Tate JE, Parashar UD, Wu HS, Hsiung CA. Effectiveness of 2 rotavirus vaccines against rotavirus disease in taiwanese infants. Pediatr Infect Dis J. 2014 Mar; 33(3):e81-6.

37. Chen L, Wang W, Du X, Rao X, van Velthoven MH, Yang R, Zhang L, Koepsell JC,  Li Y, Wu Q, Zhang Y. Effectiveness of a smart phone app on improving immunization of children in rural Sichuan Province, China: study protocol for a paired cluster randomized controlled trial. BMC Public Health. 2014 Mar 20; 14(1):262.

38. Chen YJ, Meng FY, Mao QY, Li JX, Wang H, Liang ZL, Zhang YT, Gao F, Chen QH,  Hu YM, Ge ZJ, Yao X, Guo HJ, Zhu FC, Li XL. Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial. Hum Vaccin Immunother. 2014 Mar 14;10(5). [Epub ahead of print].

39. Cherian T, Okwo-Bele JM. The decade of vaccines global vaccine action plan: shaping immunization programmes in the current decade. Expert Rev Vaccines. 2014  Mar 28. [Epub ahead of print].

40. Chou TI, Lash DB, Malcolm B, Yousify L, Quach JY, Dong S, Yu J. Effects of a  student pharmacist consultation on patient knowledge and attitudes about vaccines. J Am Pharm Assoc (2003). 2014 Mar 1;54(2):130-7.

41. Christensen LD, Eriksen HB, Biering-Sørensen S, Balé C, Do VA, Andersen A, Martins CL, Sodemann M, Aaby P, Benn CS. The effect of early measles vaccination  on thymic size. A randomized study from Guinea-Bissau. Vaccine. 2014 Mar 26; 32(15):1641-4.

42. Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent  inactivated vaccine in the United States. Hum Vaccin Immunother. 2014 Mar 7; 10(5). [Epub ahead of print].

43. Collins KC, Schlosburg JE, Lockner JW, Bremer PT, Ellis BA, Janda KD. Lipid tucaresol as an adjuvant for methamphetamine vaccine development. Chem Commun (Camb). 2014 Mar 20; 50(31):4079-81.

44. Collins KC, Janda KD. Investigating Hapten Clustering as a Strategy to Enhance Vaccines against Drugs of Abuse. Bioconjug Chem. 2014 Mar 19;25(3):593-600.

45. Costantino C, Mazzucco W, Vitale F, Azzolini E, Baldini C, Bergomi M, Biafiore AD, Bianco M, Borsari L, Cacciari P, Cadeddu C, Camia P, Carluccio E, Conti A, De Waure C, Di Gregori V, Fabiani L, Fallico R, Filisetti B, Flacco ME,  Franco E, Furnari R, Galis V, Gallea MR, Gallone MF, Gallone S, Gelatti U, Gilardi F, Giuliani AR, Grillo OC, Lanati N, Mascaretti S, Mattei A, Micò R,Morciano L, Nante N, Napoli G, Nobile C, Palladino R, Parisi S, Passaro M, Pelissero G, Quarto M, Ricciardi W, Romano G, Rustico E, Saponari A, Schioppa FS, Signorelli C, Siliquini R, Trabacchi V, Triassi M, Varetta A, Ziglio A, Zoccali A, Amodio E. Influenza vaccination coverage among medical residents: An Italian multicenter survey. Hum Vaccin Immunother. 2014 Mar 6; 10(5). [Epub ahead of print].

46. Crowe E, Pandeya N, Brotherton JM, Dobson AJ, Kisely S, Lambert SB, Whiteman  DC. Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia. BMJ. 2014 Mar 4;348:g1458.

47. Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, Fang H, Rinehart DJ, Shlay JC. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolesc Health. 2014 Mar; 54(3):282-8.

48. Dare T. Disagreement over vaccination programmes: deep or merely complex and  why does it matter? HEC Forum. 2014 Mar; 26(1):43-57.

49. Davtyan H, Ghochikyan A, Hovakimyan A, Petrushina I, Yu J, Flyer D, Madsen PJ, Pedersen LO, Cribbs DH, Agadjanyan MG. Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines. J Neuroimmunol. 2014 Mar 15;268(1-2):50-7.

50. de Souza JB. Protective immunity against malaria after vaccination. Parasite  Immunol. 2014 Mar; 36(3):131-9.

51. De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, Landry M. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine. 2014 Mar 14; 32(13):1501-6.

52. Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj  C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2014 Mar 13;3:CD001269. [Epub ahead of print] PubMed PMID:

53. Dempsey AF, Pyrzanowski J, Donnelly M, Brewer S, Barnard J, Beaty BL, Mazzoni S, O'Leary ST. Acceptability of a hypothetical group B strep vaccine among pregnant and recently delivered women. Vaccine. 2014 Mar 21. [Epub ahead of print].

54. Dey A, Gidding HF, Menzies R, McIntyre P. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events. Vaccine. 2014 Mar 6. [Epub ahead of print].

55. Dharmaraj P, Smyth RL. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev. 2014 Mar 6; 3:CD001753. [Epub ahead of print].

56. Diekema DS. Personal belief exemptions from school vaccination requirements.  Annu Rev Public Health. 2014 Mar 18; 35:275-92.

57. Diop OM, Burns CC, Wassilak SG, Kew OM; Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland. Update on vaccine-derived polioviruses - worldwide, july 2012-december 2013. MMWR Morb Mortal Wkly Rep. 2014 Mar 21; 63(11):242-8.

58. Donadiki EM, Jiménez-García R, Hernández-Barrera V, Sourtzi P, Carrasco-Garrido P, López de Andrés A, Jimenez-Trujillo I, Velonakis EG. Health Belief Model applied to non-compliance with HPV vaccine among female university students. Public Health. 2014 Mar; 128(3):268-73.

59. Durviaux S, Treanor J, Beran J, Duval X, Esen M, Feldman G, Frey SE, Launay O, Leroux-Roels G, McElhaney JE, Nowakowski A, Ruiz-Palacios GM, van Essen GA, Oostvogels L, Devaster JM, Walravens K. Genetic and antigenic typing of seasonal  influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial. Clin  Vaccine Immunol. 2014 Mar; 21(3):271-9.

60. Esposito S, Principi N. Pneumococcal vaccines and the prevention of community-acquired pneumonia. Pulm Pharmacol Ther. 2014 Mar 7. [Epub ahead of print].

61. Esposito S, Marchisio P, Prada E, Daleno C, Porretti L, Carsetti R, Bosco A,  Ierardi V, Scala A, Principi N. Impact of a mixed bacterial lysate (OM-85 BV) on  the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection. Vaccine. 2014 Mar 25. [Epub ahead of print].

62. Esposito S, Durando P, Bosis S, Ansaldi F, Tagliabue C, Icardi G; for the ESCMID Vaccine Study Group (EVASG). Vaccine-preventable diseases: From paediatric to adult targets. Eur J Intern Med. 2014 Mar; 25(3):203-212.

63. Ferdinands JM, Olsho LE, Agan AA, Bhat N, Sullivan RM, Hall M, Mourani PM, Thompson M, Randolph AG; on behalf of the Pediatric Acute Lung Injury and Sepsis  Investigators (PALISI) Network. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. J  Infect Dis. 2014 Mar 26. [Epub ahead of print].

64. Finch NA, Guarascio AJ, Suda KJ. Guillain-Barré syndrome in an older man following influenza vaccination. J Am Pharm Assoc (2003). 2014 Mar 1; 54(2):188-92.

65. Fischer Ii WA, Chason KD, Brighton M, Jaspers I. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal  epithelial cell cultures. Vaccine. 2014 Mar 26; 32(15):1761-7.

66. Flanigan J. A defense of compulsory vaccination. HEC Forum. 2014 Mar;26(1):5-25.

67. Flicoteaux R, Pulcini C, Carrieri P, Schwarzinger M, Leport C, Verger P. Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: Implications for future vaccination campaigns. Vaccine. 2014 Mar 12. [Epub ahead of print].

68. Frew PM, Saint-Victor DS, Owens LE, Omer SB. Socioecological and message framing factors influencing maternal influenza immunization among minority women. Vaccine. 2014 Mar 26;32(15):1736 44.

69. Frey SE, Winokur PL, Hill H, Goll JB, Chaplin P, Belshe RB. Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID(50)) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID(50)) in healthy vaccinia-naïve individuals. Vaccine. 2014 Mar 6. [Epub ahead of print] .

70. Fu TM, An Z, Wang D. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease. Vaccine. 2014 Mar 27. [Epub ahead of print]  Review.

71. Gai Y, Gu NY. Relationship between local family physician supply and influenza vaccination after controlling for individual and neighborhood effects.  Am J Infect Control. 2014 Mar 14. [Epub ahead of print].

72. Garrido-Estepa M, León-Gómez I, Herruzo R, Cano R. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification. Vaccine. 2014 Mar 21. [Epub ahead of print].

73. Gasparini R, Amicizia D, Domnich A, Lai PL, Panatto D. Neisseria meningitides B vaccines: recent advances and possible immunization policies. Expert Rev Vaccines. 2014 Mar; 13(3):345-64.

74. Gerin M, Wroblewski I, Bost-Bru C, N'guyen MA, Debillon T. [YEL-AND meningoencephalitis in a 4-year-old boy consecutive to a yellow-fever vaccine]. Arch Pediatr. 2014 Apr; 21(4):384-7.

75. Gillard P, Chu DW, Hwang SJ, Yang PC, Thongcharoen P, Lim FS, Dramé M, Walravens K, Roman F. Long-term booster schedules with AS03A-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults. BMC Infect Dis. 2014 Mar 15;14:142.

76. Girish GN, Ravi MD. Vaccination Related Pain: Comparison of Two Injection Techniques. Indian J Pediatr. 2014 Mar 23. [Epub ahead of print].

77. González Martínez F, Navarro Gómez ML, Saavedra Lozano J, Santos Sebastián MM, Rodríguez Fernández R, González Sanchéz M, Cercenado Mansilla E, Hernández-Sampelayo Matos T. [Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of the 7 valent conjugate vaccine]. An Pediatr (Barc). 2014 Mar;80(3):173-80.

78. Grabenstein JD, Weber DJ. Pneumococcal serotype diversity among adults in various countries, influenced by pediatric pneumococcal vaccination uptake. Clin  Infect Dis. 2014 Mar;58(6):854-64.

79. Grassly NC. Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis. J Infect Dis. 2014 Mar 14. [Epub ahead of print].

80. Greenberg RN, Gurtman A, Frenck RW, Strout C, Jansen KU, Trammel J, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine  in pneumococcal vaccine-naïve adults 60-64 years of age. Vaccine. 2014 Mar 5. [Epub ahead of print].

81. Grimaldi-Bensouda L, Le Guern V, Kone-Paut I, Aubrun E, Fain O, Ruel M, Machet L, Viallard JF, Magy-Bertrand N, Daugas E, Rossignol M, Abenhaim L, Costedoat-Chalumeau N; for the PGRx-Lupus study group.. The risk of systemic lupus erythematosus associated with vaccines: An international case control study. Arthritis Rheumatol. 2014 Mar 3. [Epub ahead of print].

82. Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A, García-Irure JJ, Navascués A, García-Cenoz M, Castilla J; Working Group for Surveillance of the Pneumococcal Disease in Navarre. Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013. Vaccine. 2014 Mar 24. [Epub ahead of print].

83. Guvenel AK, Chiu C, Openshaw PJ. Current concepts and progress in RSV vaccine development. Expert Rev Vaccines. 2014 Mar; 13(3):333-44.

84. Haas EJ, Dukhan L, Goldstein L, Lyandres M, Gdalevich M. Use of vaccination in a large outbreak of primary varicella in a detention setting for African immigrants. Int Health. 2014 Mar 28. [Epub ahead of print].

85. Hadler JL, Yousey-Hindes K, Kudish K, Kennedy ED, Sacco V, Cartter ML; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut. Impact of requiring influenza vaccination for children in licensed child care or preschool programs - connecticut, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2014 Mar 7; 63(9):181-5.

86. Hafner LM, Wilson DP, Timms P. Development status and future prospects for a vaccine against Chlamydia trachomatis infection. Vaccine. 2014 Mar 20; 32(14):1563-71.

87. Hagihara Y, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, Tominaga K, Watanabe T, Fujiwara Y, Hirota Y, Arakawa T. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. J Crohns Colitis. 2014 Mar 1; 8(3):223-33.

88. Hale SF, Camaione L, Lomaestro BM. MenHibrix: A New Combination Meningococcal Vaccine for Infants and Toddlers. Ann Pharmacother. 2014 Mar;48(3):404-11.

89. Halling G, Giannini C, Britton JW, Lee RW, Watson RE Jr, Terrell CL, Parney  IF, Buckingham EM, Carpenter JE, Grose C. Focal encephalitis following varicella-zoster virus reactivation without rash in a healthy immunized young adult. J Infect Dis. 2014 Mar 5. [Epub ahead of print].

90. Halperin SA, Baine Y, Domachowske JB, Aggarwal N, Simon M, Langley JM, McNeil SA, Friedland LR, Bianco V, Baccarini CI, Miller JM. Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age. J Pediatric Infect Dis Soc. 2014 Mar; 3(1):33-42.

91. Harris JG, Maletta KI, Ren B, Olson JC. A179: improving pneumococcal vaccination rate in the pediatric rheumatology clinic. Arthritis Rheumatol. 2014  Mar;66 Suppl 11:S234.

92. Harris KM, Uscher-Pines L, Han B, Lindley MC, Lorick SA. The impact of influenza vaccination requirements for hospital personnel in California: Knowledge, attitudes, and vaccine uptake. Am J Infect Control. 2014 Mar;42(3):288-93.

93. Hawkes S, Kismödi E, Larson H, Buse K. Vaccines to promote and protect sexual health: Policy challenges and opportunities. Vaccine. 2014 Mar 20;32(14):1610-5.

94. Hayford K, Uddin MJ, Koehlmoos TP, Bishai DM. Cost and sustainability of a successful package of interventions to improve vaccination coverage for children  in urban slums of Bangladesh. Vaccine. 2014 Mar 12. [Epub ahead of print].

95. Hense S, Hillebrand K, Horn J, Mikolajczyk R, Schulze-Rath R, Garbe E. HPV vaccine uptake after introduction of the vaccine in Germany: An analysis of administrative data. Hum Vaccin Immunother. 2014 Mar 17; 10(6). [Epub ahead of print].

96. Herzog C. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature. Expert Rev Vaccines. 2014 Mar;13(3):399-415.

97. Hofstetter AM, Rosenthal SL. Health care professional communication about STI vaccines with adolescents and parents. Vaccine. 2014 Mar 20; 32(14):1616-23.

98. Hogan ME, Probst J, Wong K, Riddell RP, Katz J, Taddio A. A randomized-controlled trial of parent-led tactile stimulation to reduce pain during infant immunization injections. Clin J Pain. 2014 Mar;30(3):259-65.

99. Holt HD, Hinkle DM, Falk NS, Fraunfelder FT, Fraunfelder FW. Human papilloma virus vaccine associated uveitis. Curr Drug Saf. 2014 Mar; 9(1):65-8.

100. Huang LM, Lin TY, Chiu CH, Chiu NC, Chen PY, Yeh SJ, Boaz M, Hutagalung Y, Bouckenooghe A, Feroldi E. Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan. Vaccine. 2014 Mar 11. [Epub ahead of print].

101. Hwang KP, Hsu YL, Hsieh TH, Lin HC, Yen TY, Wei HM, Lin HC, Chen AC, Chow JC, Huang LM. Immunogenicity and safety of a trivalent inactivated 2010-2011 influenza vaccine in Taiwan infants aged 6-12 months. Vaccine. 2014 Mar 10. [Epub ahead of print] .

102. Ivanova I, Seledtsova G, Mamaev S, Shishkov A, Seledtsov V. Immune responses induced by T-cell vaccination in patients with rheumatoid arthritis. Hum Vaccin Immunother. 2014 Mar 14; 10(5). [Epub ahead of print].

103. Jain VK, Chandrasekaran V, Wang L, Li P, Liu A, Innis BL. A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine. BMC Infect Dis. 2014 Mar 10; 14(1):133. [Epub ahead of print].

104. Javid PJ, Sanchez SE, Jacob S, McNeal MM, Horslen SP, Englund JA. The Safety and Immunogenicity of Rotavirus Vaccination in Infants With Intestinal Failure. J Pediatric Infect Dis Soc. 2014 Mar;3(1):57-65.

105. Jindal H, Bhatt B, Malik JS, Sk S, Mehta B. Malaria vaccine: A step toward elimination. Hum Vaccin Immunother. 2014 Mar 18;10(6). [Epub ahead of print].

106. Johnson S, Capdevila R. 'That's just what's expected of you ... so you do it': Mothers discussions around choice and the MMR vaccination. Psychol Health. 2014 Mar 7. [Epub ahead of print].

107. Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine. 2014 Mar 26; 32(15):1645-1653.

108. Khurana S, King LR, Manischewitz J, Coyle EM, Golding H. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency. Vaccine. 2014 Mar 6. [Epub ahead of print].

109. Kilpatrick DR, Ching K, Iber J, Chen Q, Yang SJ, De L, Williams AJ, Mandelbaum M, Sun H, Oberste MS, Kew OM. Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR. J Virol Methods. 2014 Mar;197:25-8.

110. Kim H, Schoofs P, Anderson DA, Tannock GA, Rockman SP. Cold adaptation improves the growth of seasonal influenza B vaccine viruses. Vaccine. 2014 Mar 12. [Epub ahead of print].

111. Kim YH, Hwang JY, Shim HM, Lee E, Park S, Park H. Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to  varicella. Yonsei Med J. 2014 Mar 1; 55(2):459-66.

112. Kitayama K, Stockwell MS, Vawdrey DK, Peña O, Catallozzi M. Parent perspectives on the design of a personal online pediatric immunization record. Clin Pediatr (Phila). 2014 Mar; 53(3):238-42.

113. Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK. Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial. J Rheumatol. 2014 Mar 1. [Epub ahead of print].

114. Ko KJ, Wade RL, Yu HT, Miller RM, Sherman B, Goad J. Implementation of a pharmacy-based adult vaccine benefit: recommendations for a commercial health plan benefit. J Manag Care Pharm. 2014 Mar; 20(3):273-82.

115. Kogure T, Harada N, Tatsumi T, Fujinaga H. Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis. Clin Rheumatol. 2014 Mar; 33(3):323-8.

116. Kopel E, Klempfner R, Goldenberg I. Influenza vaccine and survival in acute heart failure. Eur J Heart Fail. 2014 Mar;16(3):264-70.

117. Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P. GAD Autoantibody Affinity in Adult Patients With Latent Autoimmune Diabetes, the Study Participants of a GAD65 Vaccination Trial. Diabetes Care. 2014 Mar 5. [Epub ahead of print].

118. Kumakura S, Onoda K, Hirose M. Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan. J Infect Chemother. 2014 Mar;20(3):194-8.

119. Kung YM. A quality improvement project to increase influenza vaccination in  healthcare personnel at a university health center. J Am Assoc Nurse Pract. 2014 Mar; 26(3):148-54.

120. Kutty PK, Lawler J, Rausch-Phung E, Ortega-Sanchez IR, Goodell S, Schulte C, Pollock L, Valure B, Hudson J, Gallagher K, Blog D. Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County,  New York, 2009-2010. Hum Vaccin Immunother. 2014 Mar 14;10(5). [Epub ahead of print].

121. Lafond A, Kanagat N, Steinglass R, Fields R, Sequeira J, Mookherji S. Drivers of routine immunization coverage improvement in Africa: findings from district-level case studies. Health Policy Plan. 2014 Mar 10. [Epub ahead of print].

122. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007-2012. Vaccine. 2014 Mar 2 [Epub ahead of print].

123. Laserson U, Vigneault F, Gadala-Maria D, Yaari G, Uduman M, Vander Heiden JA, Kelton W, Taek Jung S, Liu Y, Laserson J, Chari R, Lee JH, Bachelet I, Hickey B, Lieberman-Aiden E, Hanczaruk B, Simen BB, Egholm M, Koller D, Georgiou G, Kleinstein SH, Church GM. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci U S A. 2014 Mar 17. [Epub ahead of print].

124. Lawrence HY, Hausman BL, Dannenberg CJ. Reframing Medicine's Publics: The Local as a Public of Vaccine Refusal. J Med Humanit. 2014 Mar 30. [Epub ahead of print].

125. Lee GM, Kleinman K, Pelton SI, Hanage W, Huang SS, Lakoma M, Dutta-Linn M, Croucher NJ, Stevenson A, Finkelstein JA. Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts. J Pediatric Infect Dis Soc. 2014 Mar;3(1):23-32.

126. Legge A, Dodds L, Macdonald NE, Scott J, McNeil S. Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ. 2014 Mar 4;186(4):E157-64.

127. Leroux-Roels G, Maes C, De Boever F, Traskine M, Rüggeberg JU, Borys D. Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study. Vaccine. 2014 Mar 6. [Epub ahead of print].

128. Leuzzi R, Adamo R, Scarselli M. Vaccines against Clostridium difficile.Hum Vaccin Immunother. 2014 Mar 17;10(6). [Epub ahead of print]. 

129. Li JX, Mao QY, Liang ZL, Ji H, Zhu FC. Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials. Expert Rev Vaccines. 2014 Mar 13. [Epub ahead of print].

130. Li Q, Hu Y, Zhong Y, Chen Y, Tang X, Guo J, Shen L. Using the Immunization Information System to Determine Vaccination Coverage Rates among Children Aged 1-7 Years: A Report from Zhejiang Province, China. Int J Environ Res Public Health. 2014 Mar 5; 11(3):2713-28.

131. Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI.  Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine. 2014 Mar 10;32(12):1394-7.

132. Liang Y, Ma J, Li C, Chen Y, Liu L, Liao Y, Zhang Y, Jiang L, Wang X, Che Y, Deng W, Li H, Cui X, Ma N, Ding D, Xie Z, Cui P, Ji Q, Wang J, Zhao Y, Wang J, Li Q. Safety and immunogenicity of a live attenuated mumps vaccine: A phase I clinical trial. Hum Vaccin Immunother. 2014 Mar 10; 10(5). [Epub ahead of print].

133. Licciardi PV, Russell FM, Balloch A, Burton RL, Nahm MH, Gilbert G, Tang ML, Mulholland EK. Impaired serotype-specific immune function following pneumococcal  vaccination in infants with prior carriage. Vaccine. 2014 Mar 6. [Epub ahead of print].

134. Linehan MF, Nurmatov U, Frank TL, Niven RM, Baxter DN, Sheikh A. Does BCG vaccination protect against childhood asthma? Final results from the Manchester Community Asthma Study retrospective cohort study and updated systematic review and meta-analysis. J Allergy Clin Immunol. 2014 Mar; 133(3):688-695.e14.

135. Liu Y, Lin H, Zhu Q, Wu C, Zhao Z, Zheng H. Safety of Japanese encephalitis  live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012. Vaccine. 2014 Mar 26;32(15):1768-73.

136. Luckhaupt SE, Calvert GM, Li J, Sweeney M, Santibanez TA; Division of Surveillance, Hazard Evaluations, and Field Studies, National Institute for Occupational Safety and Health, CDC. Prevalence of Influenza-Like Illness and Seasonal and Pandemic H1N1 Influenza Vaccination Coverage Among Workers - United  States, 2009-10 Influenza Season. MMWR Morb Mortal Wkly Rep. 2014 Mar 14; 63(10):217-21.

137. Luque JS, Tarasenko YN, Dixon BT, Vogel RL, Tedders SH. Recommendations and  Administration of the HPV Vaccine to 11- to 12-Year-Old Girls and Boys: A Statewide Survey of Georgia Vaccines for Children Provider Practices. J Low Genit Tract Dis. 2014 Mar 13. [Epub ahead of print].

138. Lutwama F, Kagina BM, Wajja A, Waiswa F, Mansoor N, Kirimunda S, Hughes EJ,  Kiwanuka N, Joloba ML, Musoke P, Scriba TJ, Mayanja-Kizza H, Day CL, Hanekom WA.  Distinct T-Cell Responses When BCG Vaccination Is Delayed From Birth to 6 Weeks of Age in Ugandan Infants. J Infect Dis. 2014 Mar;209(6):887-97.

139. Mabey DC, Hu V, Bailey RL, Burton MJ, Holland MJ. Towards a safe and effective chlamydial vaccine: Lessons from the eye. Vaccine. 2014 Mar 20; 32(14):1572-8.

140. Mackenzie GA, Bottomley C, van Hoek AJ, Jeffries D, Ota M, Zaman SM, Greenwood B, Cutts F. Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: Re-analysis of a randomised trial in The Gambia. Vaccine. 2014 Mar 10. [Epub ahead of print].

141. Macneil A, Dietz V, Cherian T. Vaccine preventable diseases: Time to re-examine global surveillance data? Vaccine. 2014 Mar 11. [Epub ahead of print] .

142. Madhusudana SN, Mani RS. Intradermal vaccination for rabies prophylaxis: conceptualization, evolution, present status and future. Expert Rev Vaccines. 2014 Mar 21. [Epub ahead of print].

143. Magori K, Park AW. The evolutionary consequences of alternative types of imperfect vaccines. J Math Biol. 2014 Mar;68(4):969-87.

144. Malik B, Gupta RK, Rath G, Goyal AK. Development of pH responsive novel emulsion adjuvant for oral immunization and in-vivo evaluation. Eur J Pharm Biopharm. 2014 Mar 27. pii: S0939-6411(14)00103-9. [Epub ahead of print].

145. Malik B, Rath G, Goyal AK. Are the anatomical sites for vaccine administration selected judiciously? Int Immunopharmacol. 2014 Mar;19(1):17-26.

146. Martin B. On the Suppression of Vaccination Dissent. Sci Eng Ethics. 2014 Mar 23. [Epub ahead    of print].

147. Matturri L, Del Corno G, Lavezzi AM. Sudden infant death following hexavalent vaccination: a neuropathologic study. Curr Med Chem. 2014 Mar; 21(7):941-6.

148. Maue AC, Poly F, Guerry P. A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.  Hum Vaccin Immunother. 2014 Mar 14; 10(6). [Epub ahead of print].

149. Maurer W, Seeber L, Rundblad G, Kochhar S, Trusko B, Kisler B, Kush R, Rath  B; Vienna Vaccine Safety Initiative ( www.vi-vi.org ). Standardization and simplification of vaccination records. Expert Rev Vaccines. 2014 Apr; 13(4):545-59.

150. Mayhew A, Mullins TL, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA. Risk Perceptions and Subsequent Sexual Behaviors After HPV Vaccination in Adolescents. Pediatrics. 2014 Mar;133(3):404 11.

151. McGrath EJ, Thomas R, Duggan C, Asmar BI. Pentavalent Rotavirus Vaccine in Infants with Surgical Gastrointestinal Disease: A Pilot Study. J Pediatr Gastroenterol Nutr. 2014 Mar 6. [Epub ahead of print].

152. McIntyre A, Zecevic A, Diachun L. Influenza vaccinations: older adults' decision-making process. Can J Aging. 2014 Mar; 33(1):92-8.

153. McKelvie B, Top K, McCusker C, Letenyi D, Issekutz TB, Issekutz AC. Fatal Pneumococcal Meningitis in a 7-Year-Old Girl with Interleukin-1 Receptor Activated Kinase Deficiency (IRAK-4) Despite Prophylactic Antibiotic and IgG Responses to Streptococcus Pneumoniae Vaccines. J Clin Immunol. 2014 Apr;34(3):267-71.

154. McQuaid F, Snape MD. Will booster doses be required for serogroup B meningococcal vaccine? Expert Rev Vaccines. 2014 Mar; 13(3):313-5.

155. McVernon J, Laurie K, Faddy H, Irving D, Nolan T, Barr I, Kelso A. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia. Influenza Other Respir Viruses. 2014 Mar; 8(2):194-200.

156. Mead JR. Prospects for immunotherapy and vaccines against Cryptosporidium. Hum Vaccin Immunother. 2014 Mar 17;10(6). [Epub ahead of print].

157. Mott M, Caierão J, Rosa da Cunha G, Rodrigues Perez LR, Matusiak R, Pilger de Oliveira KR, d'Azevedo PA, Dias C. Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil. Int J Infect Dis. 2014 Mar;20:47-51.

158. Murakami H, Kobayashi M, Hachiya M, Khan ZS, Hassan SQ, Sakurada S. Refusal  of oral polio vaccine in northwestern Pakistan: A qualitative and quantitative study. Vaccine. 2014 Mar 10;32(12):1382-7.

159. Murugappan S, Patil HP, Frijlink HW, Huckriede A, Hinrichs WL. Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine. AAPS J. 2014 Mar;16(2):342-9.

160. Nan X, Kim J. Predicting H1N1 Vaccine Uptake and H1N1-Related Health Beliefs: The Role of Individual Difference in Consideration of Future Consequences. J Health Commun. 2014 Mar;19(3):376 88.

161. Newall AT, Dehollain JP. The cost-effectiveness of influenza vaccination in  elderly Australians: An exploratory analysis of the vaccine efficacy required. Vaccine. 2014 Mar 10;32(12):1323-5.

162. Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Safadi MA, Cruz-Valdez A, Litao S, Seng LF, de Los Santos AM, Weber MA, Tinoco JC, Mezerville MH, Faingezicht I, Kosuwon P, Lopez P, Borja-Tabora C, Li P, Durviaux S, Fries L, Dubin G, Breuer T, Innis BL, Vaughn DW. Relative Efficacy of AS03-adjuvanted Pandemic H1N1 Influenza Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial. J Infect Dis. 2014 Mar 20. [Epub ahead of print].

163. Nyhan B, Reifler J, Richey S, Freed GL. Effective Messages in Vaccine Promotion: A Randomized Trial. Pediatrics. 2014 Mar 3. [Epub ahead of print].

164. O'Leary ST, Allison MA, Lindley MC, Crane LA, Hurley LP, Brtnikova M, Beaty  BL, Babbel CI, Jimenez-Zambrano A, Berman S, Kempe A. Vaccine financing from the  perspective of primary care physicians. Pediatrics. 2014 Mar;133(3):367-74.

165. Oh SH, Choi EH, Shin SH, Kim YK, Chang JK, Choi KM, Hur JK, Kim KH, Kim JY,  Chung EH, Lee SY, Park SE, Cha S, Kim KN, Ma SH, Eun BW, Kim NH, Jo DS, Choi BY,  Kim SA. Varicella and Varicella Vaccination in Korea. Clin Vaccine Immunol. 2014  Mar 26. [Epub ahead of print].

166. Olives C, Valadez JJ, Pagano M. Estimation after classification using lot quality assurance sampling: corrections for curtailed sampling with application to evaluating polio vaccination campaigns. Trop Med Int Health. 2014 Mar; 19(3):321-30.

167. Omura J, Buxton J, Kaczorowski J, Catterson J, Li J, Derban A, Hasselback P, Machin S, Linekin M, Morgana T, O'Briain B, Scheifele D, Dawar M. Immunization delivery in British Columbia: Perspectives of primary care physicians. Can Fam Physician. 2014 Mar; 60(3):e187-93.

168. Opel DJ, Feemster KA, Omer SB, Orenstein WA, Richter M, Lantos JD. A 6-month-old with vaccine-hesitant parents. Pediatrics. 2014 Mar; 133(3):526-30.

169. Ordóñez JE, Orozco JJ. Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia. BMC Infect Dis. 2014 Mar 28; 14(1):172. [Epub ahead of print].

170. Ozcirpici B, Aydin N, Coskun F, Tuzun H, Ozgur S. Vaccination coverage of children aged 12-23 months in Gaziantep, Turkey: comparative results of two studies carried out by lot quality technique: what changed after family medicine? BMC Public Health. 2014 Mar 3;14(1):217.

171. Ozdemir H, Ciftçi E, Durmaz R, Güriz H, Aysev AD, Karbuz A, Gökdemir R, Acar B, Nar Ötgün S, Ertek M, Köse SK, Ince E. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule. Eur J Pediatr. 2014 Mar;173(3):313-20.

172. Pacheco J, Boushey G. Public Health and Agenda Setting: Determinants of State Attention to Tobacco and Vaccines. J Health Polit Policy Law. 2014 Mar 6. [Epub ahead of print].

173. Pakkanen SH, Kantele JM, Kantele A. Cross-reactive immune response induced by the vi capsular polysaccharide typhoid vaccine against salmonella paratyphi strains. Scand J Immunol. 2014 Mar;79(3):222-9.

174. Parker EP. Advances in enteric disease vaccines: from innovation to implementation. Expert Rev Vaccines. 2014 Mar; 13(3):317-9.

175. Pasinato A, Indolfi G, Marchisio P, Valleriani C, Cortimiglia M, Spanevello  V, Chiamenti G, Buzzetti R, Resti M, Azzari C; Italian Group for the Study of Bacterial Nasopharyngeal Carriage in Children. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine. 2014 Mar 10; 32(12):1375-81.

176. Patel A, Stern L, Unger Z, Debevec E, Roston A, Hanover R, Morfesis J. Staying on track: A cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion. Vaccine. 2014 Mar 13. [Epub ahead of print].

177. Pauksens K, Nilsson AC, Caubet M, Pascal TG, Van Belle P, Poolman JT, Vandepapelière PG, Verlant V, Vink PE. Randomized Controlled Study of Pneumococcal Vaccine Formulations containing PhtD and dPly Proteins with Alum or  Adjuvant System AS02V in Elderly Adults: Safety and Immunogenicity. Clin Vaccine  Immunol. 2014 Mar 5. [Epub ahead of print].

178. Payne S, Townend J, Jasseh M, Lowe Jallow Y, Kampmann B. Achieving comprehensive childhood immunization: an analysis of obstacles and opportunities  in The Gambia. Health Policy Plan. 2014 Mar;29(2):193-203.

179. Peretti-Watel P, Raude J, Sagaon-Teyssier L, Constant A, Verger P, Beck F. Attitudes toward vaccination and the H1N1 vaccine: Poor people's unfounded fears  or legitimate concerns of the elite? Soc Sci Med. 2014 Mar 2; 109C:10-18. [Epub ahead of print].

180. PLOS ONE Staff. Correction: free-riding behavior in vaccination decisions: an experimental study. PLoS One. 2014 Mar 27;9(3):e94066.

181. PLOS ONE Staff. Correction: Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use. PLoS One. 2014 Mar 26; 9(3):e93878.

182. Pollack AH, Kronman MP, Zhou C, Zerr DM. Automated Screening of Hospitalized Children for Influenza Vaccination. J Pediatric Infect Dis Soc. 2014 Mar;3(1):7-14.

183. Prosper O, Ruktanonchai N, Martcheva M. Optimal vaccination and bednet maintenance for the control of malaria in a region with naturally acquired immunity. J Theor Biol. 2014 Mar 15. [Epub ahead of print].

184. Purohit P, Al-Obaid IA, Omar NG. The first reported case of possible Haemophilus influenzae type b vaccine failure from Kuwait and literature-review.  J Infect Public Health. 2014 March - April;7(2):99-105.

185. Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics. 2014 Mar;133(3):e513-9.

186. Ranadive SM, Cook M, Kappus RM, Yan H, Lane AD, Woods JA, Wilund KR, Iwamoto G, Vanar V, Tandon R, Fernhall B. Effect of acute aerobic exercise on vaccine efficacy in older adults. Med Sci Sports Exerc. 2014 Mar; 46(3):455-61.

187. Remschmidt C, Wichmann O, Harder T. Methodological quality of systematic reviews on influenza vaccination. Vaccine. 2014 Mar 26;32(15):1678-84.

188. Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.  Expert Rev Vaccines. 2014 Mar;13(3):365-76.

189. Richter D, Anca I, André FE, Bakir M, Chlibek R, Ci¸man M, Mangarov A, Mészner Z, Pokorn M, Prymula R, Salman N, Simurka P, Tamm E, Tešović G, Urbančíková I, Usonis V, Wysocki J, Zavadska D. Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group (CEVAG) recommendations. Expert Rev Vaccines. 2014 Mar 21. [Epub ahead of print].

190. Rivas-Santiago B, Cervantes-Villagrana AR. Novel approaches to tuberculosis  prevention: DNA vaccines. Scand J Infect Dis. 2014 Mar;46(3):161-8.

191. Rockman S, Becher D, Dyson A, Koernig S, Morelli AB, Barnden M, Camuglia S,  Soupourmas P, Pearse M, Maraskovsky E. Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine.  Vaccine. 2014 Mar 25. [Epub ahead of print].

192. Root ED, Lucero M, Nohynek H, Anthamatten P, Thomas DS, Tallo V, Tanskanen A, Quiambao BP, Puumalainen T, Lupisan SP, Ruutu P, Ladesma E, Williams GM, Riley I, Simões EA. Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children. Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3520-5.

193. Rustomjee R, Lockhart S, Shea J, Fourie PB, Hindle Z, Steel G, Hussey G, Ginsberg A, Brennan MJ. Novel licensure pathways for expeditious introduction of  new tuberculosis vaccines: a discussion of the adaptive licensure concept. Tuberculosis (Edinb). 2014 Mar; 94(2):178-82.

194. Saha S, Dean B, Teutsch S, Borse RH, Meltzer MI, Bagwell D, Plough A, Fielding J. Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009. Emerg Infect Dis. 2014 Mar; 20(3):590-5.

195. Santos JI. [Vaccination in Mexico in the context of the "vaccine decades": achievements and challenges]. Gac Med Mex. 2014 Mar-Apr; 150(2):180-8.

196. Sasaki S, Holmes TH, Albrecht RA, García-Sastre A, Dekker CL, He XS, Greenberg HB. Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines. J Infect Dis. 2014 Mar 27. [Epub ahead of print].

197. Schmidt S, Parsons HM. Vaccination Interest and Trends in Human Papillomavirus Vaccine Uptake in Young Adult Women Aged 18 to 26 Years in the United States: An Analysis Using the 2008-2012 National Health Interview Survey.  Am J Public Health. 2014 Mar 13. [Epub ahead of print].

198. Schosser R, Reichert A, Mansmann U, Unger B, Heininger U, Kaiser R. Irregular tick-borne encephalitis vaccination schedules: The effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study. Vaccine. 2014 Mar 6. [Epub ahead of print].

199. Shcherbik SV, Pearce NC, Levine ML, Klimov AI, Villanueva JM, Bousse TL. Rapid strategy for screening by pyrosequencing of influenza virus reassortants -  candidates for live attenuated vaccines. PLoS One. 2014 Mar 19; 9(3):e92580.

200. Sheikh MA, Makokha F, Hussein AM, Mohamed G, Mach O, Humayun K, Okiror S, Abrar L, Nasibov O, Burton J, Unshur A, Wannemuehler K, Estivariz CF; Ministry of Health, Kenya. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - kenya, december 2013. MMWR Morb Mortal Wkly Rep. 2014 Mar 21; 63(11):237-41.

201. Shenyu W, Jingxin L, Zhenglun L, Xiuling L, Qunying M, Fanyue M, Hua W, Yuntao Z, Fan G, Qinghua C, Yuemei H, Xin Y, Huijie G, Fengcai Z. A booster dose  of an inactivated enterovirus 71 vaccine in Chinese young children: a randomized, double-blind, placebo-controlled clinical trial. J Infect Dis. 2014 Mar 12. [Epub ahead of print].

202. Singleton RJ, Holman RC, Person MK, Steiner CA, Redd JT, Hennessy TW, Groom  A, Holve S, Seward JF. Impact of Varicella Vaccination on Varicella-related Hospitalizations Among American Indian/Alaska Native People. Pediatr Infect Dis J. 2014 Mar; 33(3):276-9.

203. Siriwardena AN, Asghar Z, Coupland CC. Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-Matched case control study. Vaccine. 2014 Mar 10; 32(12):1354-61.

204. Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA,  Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y. Low 2012-13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses. PLoS One. 2014 Mar 25;9(3):e92153.

205. Smeti P, Pavli A, Katerelos P, Maltezou HC. Typhoid vaccination for international travelers from Greece visiting developing countries. J Travel Med.  2014 Mar;21(2):99-103.

206. Song G. Understanding public perceptions of benefits and risks of childhood  vaccinations in the United States. Risk Anal. 2014 Mar; 34(3):541-55.

207. Stockwell MS, Irigoyen M, Andres Martinez R, Findley SE. Failure to Return:  Parental, Practice, and Social Factors Affecting Missed Immunization Visits for Urban Children. Clin Pediatr (Phila). 2014 Mar 18. [Epub ahead of print].

208. Stockwell MS, Broder K, Larussa P, Lewis P, Fernandez N, Sharma D, Barrett A, Sosa J, Vellozzi C. Risk of Fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine. JAMA Pediatr. 2014 Mar 1; 168(3):211-9.

209. Sundar S, Singh B. Identifying vaccine targets for anti-leishmanial vaccine  development. Expert Rev Vaccines. 2014 Mar 7. [Epub ahead of print]. 

210. Suwantika AA, Zakiyah N, Lestari K, Postma MJ. Accelerating the introduction of rotavirus immunization in Indonesia. Expert Rev Vaccines. 2014 Apr; 13(4):463-72.

211. Taddio A, Macdonald NE, Smart S, Parikh C, Allen V, Halperin B, Shah V. Impact of a parent directed pamphlet about pain management during infant vaccinations on maternal knowledge and behavior. Neonatal Netw. 2014 Mar-Apr; 33(2):74-82.

212. Taddio A, Ho T, Vyas C, Thivakaran S, Jamal A, Ilersich AF, Hogan ME, Shah V. A Randomized Controlled Trial of Clinician-Led Tactile Stimulation to Reduce Pain During Vaccination in Infants. Clin Pediatr (Phila). 2014 Mar 14. [Epub ahead of print].

213. Tafuri S, Gallone MS, Gallone MF, Aiello V, Aiello V, Germinario C. Communication about vaccinations in Italian websites: A quantitative analysis. Hum Vaccin Immunother. 2014 Mar 7; 10(5). [Epub ahead of print].

214. Takeuchi M. Bayesian network meta-analysis suggests a similar effectiveness  between a monovalent and a pentavalent rotavirus vaccine: A preliminary report of re-analyses of data from a Cochrane Database Systematic Review. Hum Vaccin Immunother. 2014 Mar 7; 10(5). [Epub ahead of print].

215. Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, McMahon BA, Karron RA, Lewis K, Qin J, Follmann D, Golding H, Neuzil K, Subbarao K. A live attenuated H5N1 vaccine induces long-term immunity in the absence of a primary antibody response. J Infect Dis. 2014 Mar 5. [Epub ahead of print].

216. Talukdar S, Zutshi S, Prashanth KS, Saikia KK, Kumar P. Identification of Potential Vaccine Candidates Against Streptococcus pneumoniae by Reverse Vaccinology Approach. Appl Biochem Biotechnol. 2014 Mar; 172(6):3026-41.

217. Tamura K, Matsubara K, Ishiwada N, Nishi J, Ohnishi H, Suga S, Ihara T, Chang B, Akeda Y, Oishi K; Japanese IPD Study Group. Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease. Vaccine. 2014 Mar 14; 32(13):1444-50.

218. Tan LJ; SHAPE Vaccine Delivery Working Group. From refrigerator to arm: Issues in vaccination delivery. Vaccine. 2014 Mar 5. [Epub ahead of print].

219. Tan M, Jiang X. Subviral particle as vaccine and vaccine platform. Curr Opin Virol. 2014 Mar 21;6C:24-33. [Epub ahead of print].

220. Tan YC, Blum LK, Kongpachith S, Ju CH, Cai X, Lindstrom TM, Sokolove J, Robinson WH. High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin Immunol. 2014 Mar; 151(1):55-65.

221. Tang DC, Nguyen HH. The Yin-Yang arms of vaccines: disease-fighting power versus tissue-destructive inflammation. Expert Rev Vaccines. 2014 Mar; 13(3):417-27.

222. Tani C, Stella M, Donnarumma D, Biagini M, Parente P, Vadi A, Magagnoli C, Costantino P, Rigat F, Norais N. Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine. Vaccine. 2014 Mar 5; 32(11):1273-9.

223. Tartof SY, Tseng HF, Liu AL, Qian L, Sy LS, Hechter RC, Michael Marcy S, Jacobsen SJ. Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014 Mar 24. [Epub ahead of print].

224. Timpka T, Spreco A, Gursky E, Eriksson O, Dahlström O, Strömgren M, Ekberg J, Pilemalm S, Karlsson D, Hinkula J, Holm E. Intentions to Perform Non-Pharmaceutical Protective Behaviors during Influenza Outbreaks in Sweden: A Cross-Sectional Study following a Mass Vaccination Campaign. PLoS One. 2014 Mar 7; 9(3):e91060.  

225. Tinoco JC, Pavia-Ruz N, Cruz-Valdez A, Aranza Doniz C, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial. Vaccine. 2014 Mar 14; 32(13):1480-7.

226. Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M. Combining multiple healthcare databases for post-marketing drug and vaccine safety surveillance: why and how? J Intern Med. 2014 Mar 17. [Epub ahead of print].

227. Trück J, Snape MD, Tatangeli F, Voysey M, Yu LM, Faust SN, Heath PT, Finn A, Pollard AJ. Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant Immunization: Follow-Up from a Randomized Controlled Trial. PLoS One. 2014 Mar 11; 9(3):e91413.

228. Ushie BA, Fayehun OA, Ugal DB. Trends and patterns of under-5 vaccination in Nigeria, 1990-2008: what manner of progress? Child Care Health Dev. 2014 Mar; 40(2):267-74.

229. Vallada MG, Okay TS, Del Negro GM, Antonio CA, Yamamoto L, Ramos SR. Accuracy of the QuantiFERON-TB Gold in Tube for diagnosing tuberculosis in a young pediatric population previously vaccinated with Bacille Calmette-Guerin. Rev Paul Pediatr. 2014 Mar; 32(1):4-10.

230. Vellinga J, Smith JP, Lipiec A, Majhen D, Lemckert AA, van Ooij M, Ives P, Yallop CA, Custers J, Havenga MJ. Challenges in manufacturing Adenoviral vectors  for global vaccine product deployment. Hum Gene Ther. 2014 Mar 4. [Epub ahead of print].

231. Vernon N, Jhaveri P. Adverse effects of adolescent immunizations. J Am Osteopath Assoc. 2014 Mar; 114(3 Suppl 1):S13-7.

232. von Elten KA, Duran LL, Banks TA, Collins LC. Systemic inflammatory reaction after pneumococcal vaccine: a case series. Hum Vaccin Immunother. 2014 Mar 18;10(6). [Epub ahead of print].

233. Wang D, Fu TM. Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease. Curr Opin Virol. 2014 Mar 12; 6C:13-23. [Epub ahead of print].

234. Weigel M, Weitmann K, Rautmann C, Schmidt J, Bruns R, Hoffmann W. Impact of  physicians' attitude to vaccination on local vaccination coverage for pertussis and measles in Germany. Eur J Public Health. 2014 Mar 5. [Epub ahead of print].

235. Weiner J, Kaufmann SH. Recent advances towards tuberculosis control: vaccines and biomarkers. J Intern Med. 2014 Mar 17. [Epub ahead of print].

236. Whiting G, Wheeler J, Rijpkema S. Identification of peptide sequences as a measure of Anthrax vaccine stability during storage. Hum Vaccin Immunother. 2014 Mar 17; 10(6). [Epub ahead of print].

237. Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA; the CAPO Investigators.  The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia  in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Vaccine. 2014 Mar 6. [Epub ahead of print].

238. Wilson FA, Wang Y, Stimpson JP. Universal paid leave increases influenza vaccinations among employees in the U.S. Vaccine. 2014 Mar 12. [Epub ahead of print].

239. Wong G, Leung T, Ng C. Outbreak of Pediatric Complicated Pneumococcal Pneumonia in the Era of Pneumococcal Conjugated Vaccine (PCV)-7 in Childhood. Chest. 2014 Mar 1; 145(3 Suppl):454B.

240. Wu Y, Gao Y, Zhu B, Zhou H, Shi Z, Wang J, Wang H, Shao Z. Antitoxins for diphtheria and tetanus decline more slowly after vaccination with DTwP than with  DTaP: A study in a Chinese population. Vaccine. 2014 Mar 25. [Epub ahead of print].

241. Xia S, Liu J. A belief-based model for characterizing the spread of awareness and its impacts on individuals' vaccination decisions. J R Soc Interface. 2014 Mar 5; 11(94):20140013.

242. Xu R, Luo Y, Glynn R, Johnson D, Jones KL, Chambers C. Time-Dependent Propensity Score for Assessing the Effect of Vaccine Exposure on Pregnancy Outcomes through Pregnancy Exposure Cohort Studies. Int J Environ Res Public Health. 2014 Mar 12; 11(3):3074-85.

243. Yamada T, Mochizuki J, Hanaoka M, Hashimoto E, Ohkuchi A, Ito M, Kubo T, Nakai A, Saito S, Unno N, Matsubara S, Minakami H. Effects of campaign for postpartum vaccination on seronegative rate against rubella among Japanese women. BMC Infect Dis. 2014 Mar 21; 14:152.

244. Yeh S, Mink C, Kim M, Naylor S, Zangwill KM, Allred NJ. Effectiveness of hospital-based postpartum procedures on pertussis vaccination among postpartum women. Am J Obstet Gynecol. 2014 Mar; 210(3):237.e1-6.

245. Zamponi N, Passamonti C, Petrelli C, Veggiotti P, Baldassari C, Verrotti A,  Capovilla G, Viri M, Coppola G, Vignoli A. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian study. Pediatr Neurol. 2014 Mar; 50(3):228-32.

246. Zawadka M, Mosiej E, Polak M, Krysztopa-Grzybowska K, Moskała B, Rokosz-Chudziak N, Rabczenko D, Augustynowicz E, Lutyńska A. Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland. Biologicals. 2014 Mar; 42(2):123-7.

247. Zhan B, Beaumier CM, Briggs N, Jones KM, Keegan BP, Bottazzi ME, Hotez PJ. Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections. Expert Rev Vaccines. 2014 Mar; 13(3):321-31.

248. Zimet GD. Health care professionals and adolescent vaccination: A call for intervention research. Hum Vaccin Immunother. 2014 Mar 18; 10(9). [Epub ahead of print].

249. Zipursky S, Djingarey MH, Lodjo JC, Olodo L, Tiendrebeogo S, Ronveaux O. Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine. 2014 Mar 14; 32(13):1431-5.

250. Çokçalışkan C, Özyörük F, Gürsoy RN, Alkan M, Günbeyaz M, Arca HÇ, Uzunlu E, Şenel S. Chitosan-based systems for intranasal immunization against foot-and-mouth disease. Pharm Dev Technol. 2014 Mar; 19(2):181-8.

 

[Top]